82W.DU Hims & Hers Health Inc
Company Analysis
Latest News
🟢 Hims & Hers Health is trading 9.83% up today with no clear catalyst
Hims & Hers Health is trading 9.83% higher at €27.26, with no clear company-specific catalyst identified for the September 22–23, 2026 move. - Coverage...
🟢 Hims & Hers Health is trading 6.69% up today with no clear company-specific catalyst identified
Hims & Hers Health is trading at €26.48, up +6.69%, with no clear company-specific catalyst identified for September 22, 2026. - Recent coverage highlighted...
🔴 Hims & Hers Health is trading 3.33% down today after FTC lawsuit reveal
Hims & Hers Health is trading 3.33% down at €24.40 after coverage said the FTC lawsuit reveal drove the stock sharply lower. - September 15, 2026 coverage...
🔴 Hims & Hers Health is trading 3.33% down today after an FTC lawsuit-related securities class-action headline
Hims & Hers Health is trading 3.33% down now at €24.40 after September 15, 2026 coverage highlighted a securities class action tied to the FTC lawsuit. - The...
🟢 Hims & Hers Health is trading 4.77% up today — no clear catalyst identified
Hims & Hers Health is trading 4.77% up at €24.60, with no clear September 14, 2026 company announcement or explicit catalyst identified in reliable...
Hims & Hers sued, alleging health data sharing and deceptive billing
Robbins Geller Rudman & Dowd LLP is seeking lead plaintiffs for a class-action lawsuit against Hims & Hers Health, Inc. The class period covers investors who...
🔴 Hims & Hers Health is trading 5% down today after FDA flags compounded GLP-1 adverse events
Hims & Hers Health is trading at €23.90 (-4.93%) after the FDA highlighted more than 1,700 adverse-event reports involving compounded semaglutide and...
🔴 Hims & Hers Health is trading 3.74% down today after FDA GLP-1 alert on 1,700+ adverse events
Hims & Hers Health is trading 3.74% down at €24.20 after an FDA warning highlighted more than 1,700 adverse events involving compounded semaglutide and...
Hims & Hers enters Australia, pivoting to branded GLP-1 weight-loss drugs
Hims & Hers Health launched its Australian operations on September 1, 2026. This expansion marks the company’s first entry into the Asia-Pacific market. The...
🔴 Hims & Hers Health is trading 6.19% down today amid Visa monitoring tied to payment disputes
Hims & Hers Health is trading at €24.84, 6.19% down now amid continued investor concern over Visa’s monitoring program tied to customer payment disputes in its...
BNY Mellon buys $46M Hims & Hers stake, backing weight-loss expansion
Bank of New York Mellon Corp purchased 1,333,146 shares of Hims & Hers Health, Inc. The new position is valued at approximately $46.22 million according to the...
🔴 Hims & Hers Health is trading 4.53% down today as investors monitor reported Visa payment-dispute concerns
Hims & Hers Health is trading at €25.28, down 4.53%, with no fresh company-specific announcement clearly explaining the August 28, 2026 decline. - Investors...
🟢 Hims & Hers Health is trading 3.52% up today as U.S. growth stocks rally
Hims & Hers Health is trading 3.52% up at €26.48 after a broader U.S. growth-stock rally on August 27, 2026. - The Nasdaq Composite gained 1.45%, while the...
🟢 Hims & Hers Health is trading 3.52% up today as U.S. growth stocks rally
Hims & Hers Health is trading at €26.48, up 3.52%, amid a broader risk-on backdrop as U.S. growth stocks rally. - The Nasdaq Composite is up 1.45%, while the...
🔴 Hims & Hers Health is trading 7.25% down today after law firms announced securities-law probes
Hims & Hers Health is trading 7.25% down now at €25.58 after multiple law firms announced investigations into potential securities-law violations on August 26,...
🟢 Hims & Hers Health is trading 5% up today — no clear catalyst identified
Hims & Hers Health is trading 5.11% up now at €27.58, with no clear company-specific catalyst identified for the August 26, 2026 move. - Recent volatility...
🟢 Hims & Hers Health is trading 3.20% up today with no clear company-specific catalyst
Hims & Hers Health is trading 3.20% up at €27.08 on August 25, 2026, with no new company-specific catalyst clearly explaining the intraday rebound. - Recent...
🔴 Hims & Hers Health is trading 8.89% down today after Visa flagged disputes over weight-loss subscriptions
Hims & Hers Health is trading at €26.24, down 8.89%, after Visa placed the company in its Acquirer Monitoring Program following a July surge in credit-card...
Visa Flags Hims & Hers Over Customer Complaints — Can a Subscription Growth Machine Survive Its Own Billing Practices?
Shares of Hims & Hers Health tumbled 8.9% to €26.24 after Bloomberg reported that Visa placed the telehealth company in its Acquirer Monitoring Program...
🔴 Hims & Hers Health is trading 8.89% down today after reports of Visa monitoring weight-loss subscriptions
Hims & Hers Health is trading 8.89% down at €26.24 after reports that Visa placed its weight-loss subscription business in a monitoring program following...